Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future

Stacey J. Adam*, Timothy G. Buchman, Judith S. Currier, Ruxandra Draghia-Akli, Josh P. Fessel, Elizabeth S. Higgs, Eric A. Hughes, Lisa Lavange, Joseph P. Menetski, Sarah W. Read, Yves Rosenberg, Randall Tressler

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The Accelerating COVID-19 Therapeutic Interventions and Vaccines Therapeutic-Clinical Working Group members gathered critical recommendations in follow-up to lessons learned manuscripts released earlier in the COVID-19 pandemic. Lessons around agent prioritization, preclinical therapeutics testing, master protocol design and implementation, drug manufacturing and supply, data sharing, and public-private partnership value are shared to inform responses to future pandemics.

Original languageEnglish
Article numbere150
JournalJournal of Clinical and Translational Science
Volume8
Issue number1
DOIs
StatePublished - 15 Oct 2024

Keywords

  • Covid-19
  • lessons learned
  • master protocol
  • therapeutics
  • trials

Cite this